Conditions We Treat

Central Serous Chorioretinopathy

CSC causes fluid to accumulate beneath the macula, leading to blurred or distorted central vision. It often resolves on its own, but some cases require treatment.

Request an Appointment

What Is Central Serous Chorioretinopathy?

Central serous chorioretinopathy (CSC) is a condition in which fluid leaks from the choroid through the retinal pigment epithelium and accumulates beneath the macula. This subretinal fluid causes the macula to detach slightly, resulting in blurred, dim, or distorted central vision.

Who Is Affected?

CSC most commonly affects men between the ages of 20 and 50. It is strongly associated with stress, elevated cortisol levels, and corticosteroid use. Type A personality traits and sleep disturbances have also been associated with the condition.

Symptoms

Blurred or dim central vision in one eye
Objects appearing smaller than normal (micropsia)
Straight lines appearing curved or distorted
A gray or dark spot in central vision
Reduced contrast sensitivity

Diagnosis

OCT imaging is the primary tool for diagnosing and monitoring CSC. Fluorescein angiography and indocyanine green angiography may be used to identify the leakage site and assess choroidal involvement.

Treatment

Acute CSC often resolves spontaneously within 3–4 months, and observation is appropriate in many cases. If fluid persists, treatment options include reduced-fluence photodynamic therapy, laser photocoagulation, or oral medications such as eplerenone or spironolactone. Corticosteroid use should be minimized or discontinued when possible.

Next Steps